HOME >> MEDICINE >> NEWS
Despite legislation, prompt payment for radiology services 'elusive goal' in New Jersey

Medical providers in New Jersey are continuing to experience payment delays even after the state has implemented prompt payment laws, a situation that could have relevance across the U.S., says a new study published in the July 2004 issue of the American Journal of Roentgenology (AJR).

The study is a follow-up to a prior publication of delayed paid claims that also appeared in the AJR. In the current work, the authors focused on unpaid claims, analyzing 48,217 claims submitted in February, June and October of 2000 to six major payers for 93 radiologists in New Jersey. The percentage of completely unpaid claims after the legal 40-day limit was 28%; after 170 days, the percentage was 6%. The study shows that lost revenue from unpaid claims was 28 times greater than the lost interest associated with delayed payments.

According to lead author on the study Lawrence C. Swayne, MD, of Morristown Memorial Hospital and Morris Imaging Associates in Morristown, NJ, the issue of prompt payment has become prominent in managed care reform. "Payment abuses have become so widespread that prompt payment laws have been enacted in 47 states. Despite these efforts, our study suggests that managed care companies may pocket close to $20 billion per year for unpaid claims at the expense of U.S. physicians," said Dr. Swayne.

And it is not just the physicians who are affected, according to Dr. Swayne. "Ultimately, the general public bears the final burden. Patients without insurance or with insufficient insurance experience decreased access. Even patients with insurance coverage frequently discover their choices are limited as physicians are forced to cease participating with a tardy payer," he said.

In addition, the study found a clean claims filing rate of 97% that, according to the researchers, contradicts the managed care organizations' assertion that about 50% of provider submitted claims are flawed. Furthermore, they said, the majority of late payme
'"/>


1-Jul-2004


Page: 1 2

Related medicine news :

1. Despite resources, at-risk infants in US fare no better, researchers find
2. Despite the best available anti-aids drugs, Jefferson scientists detect active HIV in the bloodstream
3. Despite Progress, More Action Needed To Protect Medical Students From Exposure To Disease Through Accidental Needlesticks, UCSF Study Finds
4. Many Gay Men Infected With HIV Are Opting To Delay Treatment, Despite Availability Of Drugs
5. New survey finds red dress symbol prompts women to take action to care for their hearts
6. Nerve navigation findings prompt new direction for spinal cord research
7. Activism prompts teen smokers to cut back on cigarettes, Stanford study finds
8. Common drug, given promptly, reduces incidence of post-traumatic stress disorder, small study finds
9. Antigen targeted in therapy for melanoma also prompts immune response in brain tumor cells
10. Polyherbacy prompts need for physicians advice
11. Caregiving for spouse prompts women to retire earlier

Post Your Comments:
(Date:7/30/2015)... ... 30, 2015 , ... Zaca Life has created Recovery Chewable ... water needed, the refreshing berry-flavored tablets are the perfect travel companion. , “We ... that may help with body detoxification, protection and hydration,” said Mark Aleks, Zaca ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Telemedicine Association (ATA) ... Tradeshow focused exclusively on telemedicine, telehealth and mHealth. The meeting, expected to attract ... take place May 14-17, 2016 in Minneapolis, MN. , ATA’s annual meeting attracts ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Orange, Riverside, Los Angeles, and San Bernardino counties, today announced that Dr. Michael ... Care Administrator. Dr. Demoratz is a strong proponent of early access to palliative ...
(Date:7/30/2015)... ... 2015 , ... The Beryl Institute announces its sixth annual ... Patient Experience Institute, these offerings reinforce the commitment to help frame and expand ... the experience movement, and provide information and research to support expanded focus and ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Mesothelioma Applied Research ... Patient Registry Act of 2015’. The bill was introduced in Congress yesterday by ... Betty McCollum (D-MN), Joe Kennedy (D-MA), and Leonard Lance (R-NJ). The purpose of ...
Breaking Medicine News(10 mins):Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 2Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 3Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2
(Date:7/29/2015)... July 30, 2015 Roche (SIX: RO, ROG; ... cobas® EGFR Mutation Test v2 for Premarket Approval ... (FDA), as a companion diagnostic test for AZD9291, ... cancer patients with an acquired resistant mutation.  ... who have adenocarcinoma with tumor containing an EGFR ...
(Date:7/29/2015)... 2015  Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... and supplier of injectable drug delivery systems, today announced ... the Company with flexibility and control to support its ... an equity purchase agreement for up to $45 million ... Chicago -based institutional investor, which provides the ...
(Date:7/29/2015)... BERKELEY, Calif. , July 29, 2015 /PRNewswire/ ... of the Daiichi Sankyo Group, announced today that ... clinical trial results demonstrating that the investigational drug, PLX3397, ... in most patients with tenosynovial giant cell tumor (TGCT), ... tendon sheath. Following phase 1 dose-escalation, which ...
Breaking Medicine Technology:Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy 2Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy 3Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 2Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 3Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 4Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 5
Cached News: